Reinhart Partners LLC. Increases Stock Position in Maximus, Inc. (NYSE:MMS)

Reinhart Partners LLC. increased its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 65.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 911,511 shares of the health services provider's stock after acquiring an additional 360,365 shares during the quarter. Maximus makes up about 2.3% of Reinhart Partners LLC.'s portfolio, making the stock its 21st biggest holding. Reinhart Partners LLC. owned approximately 1.61% of Maximus worth $62,156,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after buying an additional 205,564 shares during the last quarter. Mackenzie Financial Corp increased its stake in Maximus by 2.0% during the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock worth $207,687,000 after purchasing an additional 55,583 shares during the period. Dimensional Fund Advisors LP increased its stake in Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock worth $105,001,000 after purchasing an additional 177,075 shares during the period. Van Berkom & Associates Inc. increased its stake in Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after purchasing an additional 98,264 shares during the period. Finally, Fuller & Thaler Asset Management Inc. increased its stake in Maximus by 7.4% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock worth $92,188,000 after purchasing an additional 84,835 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Stock Up 0.5%

NYSE:MMS traded up $0.35 during mid-day trading on Tuesday, hitting $71.49. The stock had a trading volume of 382,322 shares, compared to its average volume of 566,193. The stock has a 50-day simple moving average of $70.26 and a two-hundred day simple moving average of $71.22. The company has a market capitalization of $4.03 billion, a PE ratio of 15.37 and a beta of 0.62. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm's revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.57 earnings per share. On average, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were paid a $0.30 dividend. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.68%. Maximus's dividend payout ratio is currently 23.86%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Insider Buying and Selling at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director now directly owns 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.